Skip to Content
Merck
  • Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.

Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.

Bioorganic & medicinal chemistry letters (2009-06-12)
Sonja Nordhoff, Silvia Cerezo-Gálvez, Holger Deppe, Oliver Hill, Meritxell López-Canet, Christian Rummey, Meinolf Thiemann, Victor G Matassa, Paul J Edwards, Achim Feurer
ABSTRACT

Modifications of DPP-4 inhibitor 5, that was discovered by structure based design, are described and structure-activity relationships discussed. With analogue 7k one of the most potent non-covalent inhibitors of DPP-4 reported to date (IC(50)=0.38nM) was discovered. X-ray structure of inhibitor 7k bound to DPP-4 revealed a hydrogen bonding interaction with Q553. First successful efforts in balancing overall properties, as demonstrated by improved metabolic stability, highlight the potential of this series.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DL-Homophenylalanine, 98%
Sigma-Aldrich
L-Homophenylalanine hydrochloride, 97%